Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “ctDNA”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT05210283
What this trial is testing

CORRECT Study of Minimal Residual Disease Detection in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Exact Sciences Corporation 1,017
Testing effectiveness (Phase 2)Ended earlyNCT05060003
What this trial is testing

Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection

Who this might be right for
Stage II Melanoma
Washington University School of Medicine 7
Not applicableUnknownNCT03771404
What this trial is testing

NSCLC Heterogeneity in Early Stage Patients and Prediction of Relapse Using a Personalized "Liquid Biopsy"

Who this might be right for
Non Small Cell Lung Cancer
Hellenic Oncology Research Group 50
Testing effectiveness (Phase 2)Looking for participantsNCT07021989
What this trial is testing

CtDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

Who this might be right for
Hodgkin Lymphoma, AdultRefractory Hodgkin LymphomaClassic Hodgkin Lymphoma
Michael Spinner, MD 38
Not applicableLooking for participantsNCT04925089
What this trial is testing

Localized Leiomyosarcoma Biomarker Protocol

Who this might be right for
Leiomyosarcoma
University of Michigan Rogel Cancer Center 40
Not applicableStudy completedNCT04254497
What this trial is testing

A Comprehensive Evaluation of Circulating Tumor DNA and Circulating Tumor Cells as a Predictive Marker in Lung Cancer

Who this might be right for
Lung Cancer
Changi General Hospital 71
Not applicableStudy completedNCT04295174
What this trial is testing

KIDSTAGE- Staging of Kidney Cancer Using Dual Time PET/CT and Other Biomarkers

Who this might be right for
Carcinoma, Renal Cell
Odense University Hospital 70
Not applicableLooking for participantsNCT04530890
What this trial is testing

Interest of Circulating Tumor DNA in Digestive and Gynecologic/Breast Cancer

Who this might be right for
Breast CancerDigestive CancerGynecologic Cancer+2 more
Poitiers University Hospital 1,000
Not applicableLooking for participantsNCT05673018
What this trial is testing

Galleri® in the Medicare Population.

Who this might be right for
Cancer
GRAIL, Inc. 50,000
Not applicableActive Not RecruitingNCT06940778
What this trial is testing

LIQUID BIOPSY FOCUSING ON CIRCULATING TUMOR CELLS AND CIRCULATING TUMOR DNA AS PRECISION MEDICINE IN GASTROINTESTINAL TUMORS

Who this might be right for
Cancer of RectumCancer of PancreasCancer of Stomach
Hospital do Coracao 273
Large-scale testing (Phase 3)Looking for participantsNCT06197425
What this trial is testing

Investigate the Efficacy of Chemotherapy in Patients With Positive ctDNA After Surgery and Adjuvant Chemotherapy for a Stage III Colorectal Cancer

Who this might be right for
Colon or Upper Rectum Adenocarcinoma
Centre Hospitalier Universitaire Dijon 1,660
Not applicableStudy completedNCT03155451
What this trial is testing

Plasma ctDNA Detection in Diagnosis of Epithelial Ovarian Cancer.

Who this might be right for
Epithelial Ovarian Cancer
RenJi Hospital 43
Not applicableLooking for participantsNCT03017573
What this trial is testing

Prospective Biobanking Study in Cancer Patients Aiming at Better Understand the Link Between the Molecular Alterations of the Tumor Itself, Its Microenvironment and Immune Response (SCANDARE)

Who this might be right for
Ovarian CancerTriple-Negative Breast CancerHead and Neck Cancer+3 more
Institut Curie 1,050
Not applicableNot Yet RecruitingNCT05629442
What this trial is testing

CtDNA and Organ Preservation/Pathologic CR in Rectal Cancer

Who this might be right for
Rectal CancerNon Metastatic Rectal Cancer
Massachusetts General Hospital 60
Not applicableLooking for participantsNCT07649629
What this trial is testing

Impact of Liquid Biopsy on the Therapeutic Pathway for Lung Cancer: Advancing the Molecular Characterization of Patients With Advanced Lung Adenocarcinoma by Integrating Liquid Biopsy Into the Early Stages of the Diagnostic and Therapeutic Pathway

Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)
Regina Elena Cancer Institute 70
Not applicableUnknownNCT05848154
What this trial is testing

Application of ctDNA in Evaluation of Neoadjuvant Chemotherapy Efficacy and Exploration of Chemoresistance Mechanisms in Pancreatic Cancer

Who this might be right for
Patients With Non-metastatic Pancreatic CancerEvaluation of Tumor Resectability Shall be Made in Consensus at Multidisciplinary Meetings, According to NCCN Guideline Version 1.2022 Pancreatic Adenocarcinoma
Shanghai Zhongshan Hospital 92
Not applicableStudy completedNCT05427617
What this trial is testing

Circulating Tumor DNA (ctDNA)-Guided Late-Line Treatment in Patients With Late-Stage Breast Cancer

Who this might be right for
Metastatic Breast CancerCirculating Tumor DNAGene Abnormality
Hunan Cancer Hospital 223
Testing effectiveness (Phase 2)Looking for participantsNCT05343013
What this trial is testing

TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy

Who this might be right for
Colorectal Cancer
M.D. Anderson Cancer Center 25
Not applicableUnknownNCT05426850
What this trial is testing

CtDNA-based MRD Assessment in Local Advanced Esophageal Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Fudan University 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04068103
What this trial is testing

Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery

Who this might be right for
Colon AdenocarcinomaStage IIA Colon Cancer AJCC v8
NRG Oncology 635
Next Page